| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ian Greer | Q21707519 |
| Naveed Sattar | Q37378984 | ||
| P2860 | cites work | Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 |
| Diet, lifestyle, and the risk of type 2 diabetes mellitus in women | Q29614196 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. | Q31936558 | ||
| Thrombosis in pregnancy: maternal and fetal issues | Q33601741 | ||
| Fetal nutrition and adult disease | Q33900856 | ||
| Cardiovascular sequelae of toxaemia of pregnancy | Q36840471 | ||
| Relation between infants' birth weight and mothers' mortality: prospective observational study | Q37319647 | ||
| Risk and prevention of type 2 diabetes in women with gestational diabetes | Q40846547 | ||
| Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia | Q41020037 | ||
| Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors | Q43518966 | ||
| Association of maternal endothelial dysfunction with preeclampsia | Q43553727 | ||
| Death rates from ischemic heart disease in women with a history of hypertension in pregnancy | Q44845053 | ||
| Birth dimensions of offspring, premature birth, and the mortality of mothers | Q46353902 | ||
| Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus | Q46451754 | ||
| The remote prognosis in toxemia of pregnancy | Q46632139 | ||
| Gestational diabetes diagnostic criteria: long-term maternal follow-up. | Q51590752 | ||
| Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. | Q52237839 | ||
| Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births | Q61847698 | ||
| The remote prognosis of eclamptic women. Sixth periodic report | Q67441842 | ||
| Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis | Q69654388 | ||
| Hypertension in pregnancy: clinical-pathological correlations and remote prognosis | Q70803180 | ||
| Hyperinsulinemia 17 years after preeclamptic first pregnancy | Q71432870 | ||
| Lipid levels in former gestational diabetic mothers | Q71829379 | ||
| Beginning regular exercise in early pregnancy: effect on fetoplacental growth | Q73305905 | ||
| Is normal pregnancy atherogenic? | Q74625067 | ||
| Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia | Q77425044 | ||
| Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process | Q77897500 | ||
| P433 | issue | 7356 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 157-160 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? | |
| P478 | volume | 325 |
| Q36082101 | "Just because you're pregnant, doesn't mean you're sick!" A qualitative study of beliefs regarding physical activity in black South African women |
| Q33591844 | 10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study. |
| Q92863129 | A Protocol for Nurse-Practitioner Led Cardiovascular Follow-Up After Pregnancy Complications in a Socioeconomically Disadvantaged Population |
| Q90018009 | A clinical prescription for heart health in midlife women |
| Q26827543 | A lesson for cancer research: placental microarray gene analysis in preeclampsia |
| Q35218112 | A life course approach to cardiovascular aging |
| Q36418586 | A life course approach to reproductive health: theory and methods |
| Q57300709 | ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study |
| Q38903920 | ACE gene in pregnancy complications: Insights into future vascular risk |
| Q36486994 | Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. |
| Q39624198 | Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus. |
| Q46567506 | Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity |
| Q47162288 | Adolescent Childbirth Is Associated With Greater Framingham Risk Scores for Cardiovascular Disease Among Participants of the IMIAS (International Mobility in Aging Study). |
| Q38283938 | Advice on exercise for pregnant women with hypertensive disorders of pregnancy |
| Q37035990 | Age at birth of first child and coronary heart disease risk factors at age 53 years in men and women: British birth cohort study |
| Q35592481 | Alterations in maternal and fetal heart functions accompany failed spiral arterial remodeling in pregnant mice |
| Q84675826 | Antepartum and postpartum maternal plasma levels of E-selectin in pre-eclampsia, gestational proteinuria and gestational hypertension |
| Q61816872 | Appropriate Interventions for Pregnant Women with Indicators of Metabolic Syndrome on Pregnancy Outcomes: A Systematic Review |
| Q34315724 | Arterial stiffness and wave reflection 1 year after a pregnancy complicated by hypertension |
| Q41052425 | Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia |
| Q90349947 | Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years Postpartum |
| Q49832330 | Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease |
| Q41138600 | Association of Women's Reproductive History With Long-term Mortality and Effect of Socioeconomic Factors |
| Q33831275 | Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study |
| Q34288009 | Association of parity with carotid diameter and distensibility: multi-ethnic study of atherosclerosis |
| Q34112751 | Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort |
| Q37576807 | Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study |
| Q35882065 | Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children |
| Q34724369 | Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study |
| Q40562169 | Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. |
| Q36746936 | Biological rhythms and preeclampsia |
| Q39117792 | Biomarkers of oxidative stress in pregnancy complications. |
| Q34169172 | Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women |
| Q91714493 | Cardiometabolic Risk Factors in Pregnancy and Implications for Long-Term Health: Identifying the Research Priorities for Low-Resource Settings |
| Q57178877 | Cardiovascular biomarkers in the years following pregnancies complicated by hypertensive disorders or delivered preterm |
| Q36428404 | Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study |
| Q34756489 | Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up study |
| Q45012820 | Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). |
| Q34999438 | Cardiovascular risk factors one year after a hypertensive disorder of pregnancy |
| Q36404371 | Cardiovascular risk in women after metabolic complications in pregnancy |
| Q51337680 | Cardiovascular risk profile of mothers of a Portuguese birth cohort: a survey 4 years after delivery. |
| Q34599422 | Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin |
| Q38426044 | Childhood and adulthood socio-economic position and hypertensive disorders in pregnancy: the Uppsala Birth Cohort Multigenerational Study |
| Q54710347 | Clustering of metabolic risk factors and adverse pregnancy outcomes: a prospective cohort study. |
| Q92028318 | Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes |
| Q85100347 | Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome |
| Q39418430 | Copeptin concentrations are not elevated in gestational diabetes mellitus |
| Q57267951 | Counselling and management of cardiovascular risk factors after preeclampsia |
| Q38768992 | Cumulative lactation and onset of hypertension in African American women |
| Q33293721 | Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia |
| Q36688687 | Determinants of incident hyperglycemia 6 years after delivery in young rural Indian mothers: the Pune Maternal Nutrition Study (PMNS). |
| Q33579089 | Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013). |
| Q51011537 | Diagnosis and treatment of hypertension 21 years after a hypertensive disorder of pregnancy. |
| Q93109012 | Disturbed Cardiorespiratory Adaptation in Preeclampsia: Return to Normal Stress Regulation Shortly after Delivery? |
| Q39506492 | Does a history of hypertensive disorders of pregnancy help predict future essential hypertension? Findings from a prospective pregnancy cohort study. |
| Q36102168 | Does pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study |
| Q80160254 | Does pregnancy-induced hypertension increase the risk of developing metabolic syndrome? |
| Q35881739 | Dysfunction of Liver Receptor Homolog-1 in Decidua: Possible Relevance to the Pathogenesis of Preeclampsia |
| Q44441131 | Early antenatal serum lipid levels and the risk of pre-eclampsia in Trinidad and Tobago |
| Q34487121 | Early life opportunities for prevention of diabetes in low and middle income countries |
| Q59797694 | Effect of premature birth on long-term systolic blood pressure variability in women |
| Q36925455 | Endothelial function in women with and without a history of glucose intolerance in pregnancy |
| Q47697793 | Evaluating the association between all components of the metabolic syndrome and pre-eclampsia. |
| Q41420013 | Exercise in pregnancy does not alter gestational weight gain, MCP-1 or leptin in obese women |
| Q34072217 | Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats |
| Q47805482 | Exposure to omentum adipose tissue conditioned medium from obese pregnant women promotes myometrial artery dysfunction |
| Q50891430 | Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats. |
| Q40402667 | Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. |
| Q38056887 | From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system? |
| Q89391735 | Gene-Centric Analysis of Preeclampsia Identifies Maternal Association at PLEKHG1 |
| Q37108031 | Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia |
| Q36950133 | Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease |
| Q34202996 | Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene |
| Q58605484 | Gestational diabetes and ultrasound-assessed fetal growth in South Asian and White European women: findings from a prospective pregnancy cohort |
| Q37950851 | Gestational diabetes: implications for cardiovascular health |
| Q33879112 | Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women |
| Q50655957 | Greater pressor reactivity in women with pre-eclampsia is not related to specific psychological or emotional stressors. |
| Q57047924 | Growing body of evidence supports intrauterine insemination as first line treatment and rejects unfounded concerns about its efficacy, risks and cost effectiveness |
| Q41724768 | Harnessing the Power of Pregnancy and Pregnancy-Related Events to Predict Cardiovascular Disease in Women |
| Q38563714 | Health after pregnancy in the mother with diabetes |
| Q58767260 | History of Preeclampsia Adds to the Deleterious Effect of Chronic Stress on the Cardiac Ability to Flexibly Adapt to Challenge |
| Q34297188 | History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the Coronary Artery Risk Development in Young Adults study |
| Q36980294 | Hypertension in pregnancy: an emerging risk factor for cardiovascular disease |
| Q89414117 | Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study |
| Q92320019 | Hypertensive disorders of pregnancy and cardiometabolic outcomes in childhood: A systematic review |
| Q38781105 | Hypertensive disorders of pregnancy increase the risk for chronic kidney disease: A population-based retrospective study |
| Q37763163 | Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management |
| Q40818611 | Improving the postpartum care of women with a recent history of preeclampsia: a focus group study |
| Q42700838 | In Utero Exposure to a Cardiac Teratogen Causes Reversible Deficits in Postnatal Cardiovascular Function, But Altered Adaptation to the Burden of Pregnancy |
| Q61798223 | Increased biosynthesis and accumulation of cholesterol in maternal plasma, but not amniotic fluid in pre-eclampsia |
| Q92393610 | Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events |
| Q37489759 | Investigation of the actin scavenging system in pre-eclampsia |
| Q36823766 | Left ventricle diastolic dysfunction in diabetes: an update |
| Q58130000 | Life Course Trajectories of Cardiovascular Risk Factors in Women With and Without Hypertensive Disorders in First Pregnancy: The HUNT Study in Norway |
| Q33897034 | Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study |
| Q37959563 | Linking preeclampsia and cardiovascular disease later in life |
| Q39903413 | Lipid levels including oxidized LDL in women with history of preeclampsia |
| Q57606231 | Lipoprotein metabolism and vascular complications in pregnancy |
| Q40396452 | Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children |
| Q38651066 | Long-Term Effects of Pregnancy Complications on Maternal Health: A Review. |
| Q39156564 | Maternal Lipids May Predict Fetal Growth in Type 2 Diabetes Mellitus and Gestational Diabetes Mellitus Pregnancies |
| Q92511804 | Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women |
| Q45090255 | Maternal cardiac risks in pre-eclamptic patients |
| Q52931588 | Maternal hemodynamics: a 2017 update. |
| Q39260377 | Maternal obesity impairs specific regulatory pathways in human myometrial arteries |
| Q81193807 | Maternal obesity: a problem for both mother and child |
| Q37958247 | Maternal obesity: implications for pregnancy outcome and long-term risks-a link to maternal nutrition |
| Q36670594 | Maternal serum adiponectin multimers in gestational diabetes |
| Q38889941 | Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis |
| Q48149570 | Metabolic changes, hypothalamo-pituitary-adrenal axis and oxidative stress after short-term starvation in healthy pregnant women |
| Q31021082 | Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease |
| Q33612318 | Microvascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators |
| Q58756715 | Midlife development of type 2 diabetes and hypertension in women by history of hypertensive disorders of pregnancy |
| Q55426884 | Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats. |
| Q48158589 | Motivators and barriers to a healthy postpartum lifestyle in women at increased cardiovascular and metabolic risk: a focus-group study |
| Q90569660 | Number of parity is associated with low-grade albuminuria in middle-aged and elderly Chinese women |
| Q37713422 | Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial |
| Q40348358 | Offspring birthweight by gestational age and parental cardiovascular mortality: a population-based cohort study |
| Q36302792 | Oxfordshire Women and Their Children's Health (OxWATCH): protocol for a prospective cohort feasibility study |
| Q58623914 | PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE |
| Q43249318 | Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of pre-eclampsia |
| Q55006204 | Parenthood and the risk of cardiovascular diseases among 0.5 million men and women: findings from the China Kadoorie Biobank. |
| Q37059325 | Parenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals. |
| Q36320756 | Parity and Risk of Coronary Heart Disease in Middle-aged and Older Chinese Women |
| Q37267113 | Parity and serum lipid levels: a cross-sectional study in chinese female adults |
| Q91603558 | Parity is associated with albuminuria and chronic kidney disease: a population-based study |
| Q84944622 | Parity is associated with increased waist circumference and other anthropometric indices of obesity |
| Q91909798 | Perinatal outcomes of monochorionic diamniotic triplet pregnancies: a case series |
| Q40693329 | Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status |
| Q36990027 | Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden |
| Q48325496 | Placental development and function in women with a history of placenta-related complications: a systematic review. |
| Q41090396 | Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study. |
| Q33616637 | Plasma Vitamin D Deficiency Is Associated With Poor Sleep Quality and Night-Time Eating at Mid-Pregnancy in Singapore. |
| Q34154645 | Postpartum healthcare after gestational diabetes and hypertension |
| Q93222178 | Postpregnancy BMI in the Progression From Hypertensive Disorders of Pregnancy to Type 2 Diabetes |
| Q81446389 | Pre-eclampsia |
| Q42713250 | Pre-eclampsia and increased cardiovascular risk |
| Q37186227 | Pre-eclampsia and long-term maternal health |
| Q26747071 | Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease |
| Q36885556 | Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia: Cohort Norway Study |
| Q56341952 | Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus |
| Q34567015 | Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort |
| Q46320384 | Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases. |
| Q36752103 | Preeclampsia and future cardiovascular risk. |
| Q35143007 | Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease |
| Q47587665 | Pregnancies After the Diagnosis of Mild Gestational Diabetes Mellitus and Risk of Cardiometabolic Disorders |
| Q36730315 | Pregnancy Complications as Markers for Subsequent Maternal Cardiovascular Disease: Validation of a Maternal Recall Questionnaire |
| Q36663565 | Pregnancy as a Window to Future Cardiovascular Health: Design and Implementation of the nuMoM2b Heart Health Study |
| Q30251492 | Pregnancy as a critical window for blood pressure regulation in mother and child: programming and reprogramming. |
| Q38136386 | Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? |
| Q37534763 | Pregnancy complications and calculated cardiovascular risk in urban women: do we envisage an association? |
| Q38961680 | Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. |
| Q44972750 | Pregnancy outcome among women universally screened for gestational diabetes mellitus with a lime-flavoured drink |
| Q87811158 | Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology |
| Q36723022 | Pregnancy-Associated Hypertension in Glucose-Intolerant Pregnancy and Subsequent Metabolic Syndrome |
| Q55483234 | Pregnancy-Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population-Based Norwegian Cohort. |
| Q33559194 | Pregnancy: An Underutilized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication |
| Q35587249 | Pregnancy: a stress test for life |
| Q37669518 | Prepregnancy body mass index and cardiovascular disease mortality: the Child Health and Development Studies |
| Q36128984 | Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study |
| Q34032027 | Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study |
| Q41213050 | Present status of clinical care for postpartum patients with hypertensive disorders of pregnancy in Japan: findings from a nationwide questionnaire survey. |
| Q47731262 | Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta-Analysis. |
| Q57156915 | Preterm Delivery and Maternal Cardiovascular Disease Risk Factors: The Nurses' Health Study II |
| Q40353050 | Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women |
| Q36641880 | Preterm birth and future maternal blood pressure, inflammation, and intimal-medial thickness: the CARDIA study |
| Q36854224 | Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control study |
| Q47097096 | Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when. |
| Q45125370 | Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome |
| Q37311066 | Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model |
| Q36131509 | Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort |
| Q43511876 | Relation of periodontitis and metabolic syndrome with gestational glucose metabolism disorder. |
| Q33971284 | Relationships of risk factors for pre-eclampsia with patterns of occurrence of isolated gestational proteinuria during normal term pregnancy |
| Q35743816 | Renin angiotensin signaling in normal pregnancy and preeclampsia |
| Q90629999 | Reproduction, DNA methylation and biological age |
| Q57167914 | Residual Vascular Dysfunction in Women with a History of Preeclampsia |
| Q37354555 | Retrospective cohort study on risk factors for development of gestational diabetes among mothers attending antenatal clinics in Nairobi County |
| Q40220430 | Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction |
| Q38093204 | Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study |
| Q33895447 | Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the women's health initiative |
| Q39706974 | Risk of coronary artery disease in women with history of pregnancies complicated by preeclampsia and LBW. |
| Q90725017 | Role of Corin in Blood Pressure Regulation in Normotensive and Hypertensive Pregnancy |
| Q34176478 | Role of dyslipidemia in preeclamptic overweight pregnant women |
| Q36034224 | Second trimester anti-angiogenic proteins and preeclampsia |
| Q46236309 | Serum ßhCG and lipid profile in early second trimester as predictors of pregnancy induced hypertension |
| Q33770112 | Serum βhCG and Lipid Profile in Early Second Trimester as Predictors of Pregnancy-Induced Hypertension |
| Q52578791 | Sex Differences in the Burden and Complications of Diabetes. |
| Q96955188 | Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice |
| Q33577443 | Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis |
| Q37052645 | Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia |
| Q37642835 | Short- and long-term strategies for the management of hypertensive disorders of pregnancy |
| Q46348546 | Social stigma and compounded losses: quality-of-life issues for multiple-birth families |
| Q53536660 | Soluble Flt-1 links microvascular disease with heart failure in CKD. |
| Q37399072 | Strategies to Promote Physical Activity During Pregnancy: A Systematic Review of Intervention Evidence |
| Q30907511 | Subsequent risk of metabolic syndrome in women with a history of preeclampsia: data from the Health Examinees Study |
| Q38832901 | Sympathetic neural and cardiovascular responses during static handgrip exercise in women with a history of hypertensive pregnancy |
| Q28395714 | Telomere length, pre-eclampsia, and gestational diabetes |
| Q59329286 | The Immunogenetic Conundrum of Preeclampsia |
| Q51096234 | The Influence of Lipid and Proinflammatory Status on Maternal Uterine Blood Flow in Women With Late Onset Gestational Diabetes. |
| Q33346323 | The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis |
| Q36207134 | The Risk Factors That Predict Chronic Hypertension After Delivery in Women With a History of Hypertensive Disorders of Pregnancy |
| Q48529014 | The Society for Social Medicine John Pemberton Lecture 2011. Developmental overnutrition--an old hypothesis with new importance? |
| Q33589379 | The design of a community lifestyle programme to improve the physical and psychological well-being of pregnant women with a BMI of 30 kg/m2 or more |
| Q36133797 | The effect of age, obesity and parity on blood pressure and hypertension in non-pregnant married women |
| Q50105640 | The effect of lifestyle interventions on maternal body composition during pregnancy in developing countries: a systematic review |
| Q44623007 | The effect of parity on cause-specific mortality among married men and women |
| Q36356888 | The evidence linking maternal nutrition and prematurity |
| Q34629295 | The importance of early life in childhood obesity and related diseases: a report from the 2014 Gravida Strategic Summit |
| Q37234812 | The loss of sustained Ca(2+) signaling underlies suppressed endothelial nitric oxide production in preeclamptic pregnancies: implications for new therapy |
| Q35562296 | The relationship between fertility and lifespan in humans |
| Q35293014 | The relationship between metabolic syndrome criteria and preeclampsia in primigravid women |
| Q38592484 | Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis. |
| Q35086448 | Utilization of primary and obstetric care after medically complicated pregnancies: an analysis of medical claims data. |
| Q24632982 | VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q89661754 | Validity of self-reported and objectively measured sedentary behavior in pregnancy |
| Q39584490 | Vascular risk in women with a history of severe preeclampsia |
| Q38820339 | What we have learned about treating mild gestational diabetes mellitus |
| Q33812598 | Women with gestational diabetes should be targeted to reduce cardiovascular risk |
Search more.